Exhibit 5.1.1
| | |
 | | Davis Polk & WardwellLLP 450 Lexington Avenue New York, NY 10017 davispolk.com |
July 28, 2022
Re: | CSX Corporation – $950,000,000 aggregate principal amount of its 4.100% Notes due 2032, $900,000,000 aggregate principal amount of its 4.500% Notes due 2052 and $150,000,000 aggregate principal amount of its 4.650% Notes due 2068 |
CSX Corporation
500 Water Street, 15th Floor
Jacksonville, Florida 32202
Ladies and Gentlemen:
CSX Corporation, a Virginia corporation (the “Company”), has filed with the Securities and Exchange Commission a registration statement on Form S-3 (File No. 333-262788) (the “Registration Statement”) for the purpose of registering under the Securities Act of 1933, as amended (the “Securities Act”), certain securities, including the Company’s $950,000,000 aggregate principal amount of its 4.100% Notes due 2032 (the “2032 Notes”), $900,000,000 aggregate principal amount of its 4.500% Notes due 2052 (the “2052 Notes”) and an additional $150,000,000 aggregate principal amount of its existing 4.650% Notes due 2068 (the “2068 Reopening Notes” and, together with the 2032 Notes and the 2052 Notes, the “Securities”). The 2068 Reopening Notes are to be issued pursuant to the provisions of the Indenture dated as of August 1, 1990, between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), successor to JPMorgan Chase Bank, N.A. (formerly The Chase Manhattan Bank), as trustee (the “Trustee”), as supplemented and amended by the First Supplemental Indenture dated as of June 15, 1991, the Second Supplemental Indenture dated as of May 6, 1997, the Third Supplemental Indenture dated as of April 22, 1998, the Fourth Supplemental Indenture dated as of October 30, 2001, the Fifth Supplemental Indenture dated as of October 27, 2003, the Sixth Supplemental Indenture dated as of September 23, 2004, the Seventh Supplemental Indenture dated as of April 25, 2007 and the Eighth Supplemental Indenture dated as of March 24, 2010 (collectively, the “Original Indenture”). The 2032 Notes and the 2052 Notes are to be issued under the Original Indenture, as supplemented and amended by the Ninth Supplemental Indenture dated February 12, 2019, the Tenth Supplemental Indenture dated as of December 10, 2020 and the Eleventh Supplemental Indenture dated as of July 28, 2022 (together with the Original Indenture, the “Indenture”). The 2068 Reopening Notes will constitute a further issuance of, and will form a single series with, the Company’s outstanding 4.650% Notes due 2068 issued on February 20, 2018 in the original aggregate principal amount of $350,000,000. The Notes are to be sold pursuant to the Underwriting Agreement dated July 21, 2022 (the “Underwriting Agreement”) among the Company and the several underwriters named therein (the “Underwriters”).
We, as your counsel, have examined originals or copies of such documents, corporate records, certificates of public officials and other instruments as we have deemed necessary or advisable for the purpose of rendering this opinion.
In rendering the opinion expressed herein, we have, without independent inquiry or investigation, assumed that (i) all documents submitted to us as originals are authentic and complete, (ii) all documents submitted to us as copies conform to authentic, complete originals, (iii) all signatures on all documents that we reviewed are genuine, (iv) all natural persons executing documents had and have the legal capacity to do so, (v) all statements in certificates of public officials and officers of the Company that we reviewed were and are accurate and (vi) all representations made by the Company as to matters of fact in the documents that we reviewed were and are accurate.